Integral Health Asset Management LLC Makes New Investment in Centene Corporation $CNC

Integral Health Asset Management LLC bought a new stake in Centene Corporation (NYSE:CNC) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 400,000 shares of the company’s stock, valued at approximately $14,272,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. WPG Advisers LLC increased its holdings in shares of Centene by 44.5% during the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after purchasing an additional 282 shares during the period. Versant Capital Management Inc grew its position in Centene by 11.6% during the third quarter. Versant Capital Management Inc now owns 3,421 shares of the company’s stock worth $122,000 after buying an additional 355 shares in the last quarter. Snowden Capital Advisors LLC increased its stake in Centene by 8.0% during the second quarter. Snowden Capital Advisors LLC now owns 5,073 shares of the company’s stock valued at $275,000 after acquiring an additional 374 shares during the period. MAI Capital Management raised its holdings in Centene by 6.3% in the 3rd quarter. MAI Capital Management now owns 6,545 shares of the company’s stock valued at $234,000 after acquiring an additional 388 shares in the last quarter. Finally, Financial Network Wealth Advisors LLC lifted its position in Centene by 54.9% in the third quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after purchasing an additional 390 shares during the period. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Trading Down 0.3%

CNC stock opened at $34.47 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.87. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $66.03. The company has a market cap of $16.95 billion, a P/E ratio of -2.53, a PEG ratio of 0.77 and a beta of 0.48. The business has a fifty day moving average of $42.81 and a 200-day moving average of $38.33.

Centene (NYSE:CNC) last issued its quarterly earnings results on Friday, February 6th. The company reported ($1.19) EPS for the quarter, topping the consensus estimate of ($1.22) by $0.03. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The company had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. During the same quarter in the previous year, the company earned $0.80 EPS. Centene’s revenue was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, equities research analysts expect that Centene Corporation will post 6.86 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CNC. Cantor Fitzgerald restated a “neutral” rating and issued a $41.00 price objective on shares of Centene in a research note on Monday, February 9th. JPMorgan Chase & Co. boosted their price target on Centene from $38.00 to $45.00 and gave the company a “neutral” rating in a research note on Thursday, January 22nd. Wells Fargo & Company set a $44.00 price objective on Centene and gave the stock an “equal weight” rating in a research note on Wednesday, February 18th. Morgan Stanley boosted their target price on shares of Centene from $38.00 to $45.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 4th. Finally, Wall Street Zen cut shares of Centene from a “buy” rating to a “hold” rating in a research note on Sunday, February 15th. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $42.06.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.